SZodixStudyAcademic Library
ShelvesOpen access
Study · an open academic library·Metadata from OpenAlex (CC0)·Shelves·OpenAlex metadata, de-duplicated
Impact of reference-based pricing of nitrates on the use and costs of anti-anginal drugs.
4 references·1 citing·19 second hop
Impact of reference-based pricing of nitrates on the use and costs of anti-anginal drugs. (2001)Impact of reference-based pricing of nitr…Pharmaceutical Reference Prices (1998)Pharmaceutical Reference Pric…The Strategic Response by Pharmaceutical Firms to the Medicaid Most-Favored-Customer Rules (1996)The Strategic Response by Pha…Price regulation of drugs: Lessons from Germany (1996)Price regulation of drugs: Le…Fixing health budgets: experience from Europe and North America (1996)Fixing health budgets: experi…Clinical and economic consequences of reference pricing for dihydropyridine calcium channel blockers (2003)Clinical and economic consequ…Consumer Demand. A New Approach. (1972)Consumer Demand: A New Approach. (1975)What Happened to Americans' Support for the Clinton Health Plan? (1995)Review of the Literature on Reference Pricing (1999)Reference Pricing of Pharmaceuticals for Medicare: Evidence from Germany, the Netherlands and New Zealand (2003)An overview of pharmaceutical policy in four countries: France, Germany, the Netherlands and the United Kingdom (2005)Effects of Medicaid Drug-Payment Limits on Admission to Hospitals and Nursing Homes (1991)METHODS FOR ANALYZING HEALTH CARE UTILIZATION AND COSTS (1999)Adverse Events Associated With Prescription Drug Cost-Sharing Among Poor and Elderly Persons (2001)The Effects of Third-Degree Price Discrimination in Oligopoly.Price Discrimination in Free-Entry Markets (1985)Generic Entry and the Pricing of Pharmaceuticals (1997)The Medicare Prescription Drug Benefit: How Will The Game Be Played? (2000)Should Drug Prices Be Negotiated Under Part D Of Medicare? And If So, How? (2008)Priority-setting and rationing in German health care (1999)Appraising the financial reform in Bulgarian public health care sector: the health insurance act of 1998 (2000)Pharmaceutical policies: effects of financial incentives for prescribers (2007)Impact of reference-based pricing for histamine-2 receptor antagonists and restricted access for proton pump inhibitors in British Columbia. (2002)Do policy changes in the pharmaceutical reimbursement schedule affect drug expenditures? (2006)
this work references cited by second hop

References

  • 1996The Strategic Response by Pharmaceutical Firms to the Medicaid Most-Favored-Customer Rules75 cited
  • 1996Price regulation of drugs: Lessons from Germany73 cited
  • 1998Pharmaceutical Reference Prices66 cited
  • 1996Fixing health budgets: experience from Europe and North America46 cited

Cited by

  • 2003Clinical and economic consequences of reference pricing for dihydropyridine calcium channel blockers59 cited

Only edges whose both ends are imported exist here. Widen the year window, or show the whole map. Back to the work